Loading...
By Kelly Young
Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM
The American Medical Association has recommended banning direct-to-consumer advertising for medical devices and drugs in an effort to slow the growth of prescription drug costs.
The new policy, adopted at the group's interim meeting, is in response to concerns that advertising directly to consumers increases demand for newer, pricier drugs, when such treatment may not always be appropriate.
The AMA also plans to launch a task force and campaign to push for more transparent pricing and for affordable prescription drugs through choice and competition.
In addition, the group will support federal agencies' efforts to regulate drug companies' attempts to stifle generic competition.
Comment
LINK(S):
American Medical Association news release (Free)
Background: NEJM Journal Watch General Medicine coverage of TV ads for statins (Your NEJM Journal Watch registration required)